{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:06:32Z","timestamp":1792181192187,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010428","name":"Innovation and Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.maturitas.2024.108128","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T18:51:55Z","timestamp":1727549515000},"page":"108128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficacy and safety of an ultra-low-dose 0.005\u00a0% estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial"],"prefix":"10.1016","volume":"190","author":[{"given":"Nuno","family":"Mui\u00f1os Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Mart\u00ednez Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Pardo Gonz\u00e1lez de Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Pilar","family":"Diz Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Palomo Alameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Duce Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Gonz\u00e1lez B\u00e9jar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Rabanal Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rosado Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Noguera Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Doyle Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Rodr\u00edguez Mariblanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Garc\u00eda Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2024.108128_bb0005","unstructured":"Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia. Infecciones del tracto urinario inferior. Gu\u00eda de asistencia pr\u00e1ctica. [Lower urinary tract infections. Clinical Practice Guideline]. Prog Obstet Ginecol 2021;64:200\u2013210."},{"key":"10.1016\/j.maturitas.2024.108128_bb0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.maturitas.2015.04.014","article-title":"The management of urinary tract infections in octogenarian women","volume":"81","author":"Robinson","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2024.108128_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00192-014-2569-5","article-title":"Recurrent urinary tract infections in women","volume":"26","author":"Aydin","year":"2015","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.maturitas.2024.108128_bb0020","first-page":"501","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005131. Peck J, Shepherd JP. Recurrent urinary tract infections: diagnosis, treatment, and prevention","volume":"48","author":"Perrotta","year":"2021","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.maturitas.2024.108128_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ogc.2021.05.005","article-title":"Recurrent urinary tract infections: diagnosis, treatment, and prevention","volume":"48","author":"Peck","year":"2021","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.maturitas.2024.108128_bb0030","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00192-021-04832-9","article-title":"The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections","volume":"33","author":"Anglim","year":"2022","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.maturitas.2024.108128_bb0035","series-title":"S\u00edndrome genitourinario de la menopausia","author":"Baquedano","year":"2020"},{"key":"10.1016\/j.maturitas.2024.108128_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/13697137.2014.946279","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s sexual health and the Noth American menopause society","volume":"17","author":"Portman","year":"2014","journal-title":"Climateric"},{"key":"10.1016\/j.maturitas.2024.108128_bb0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/13697137.2018.1551871","article-title":"The etiology and management of recurrent urinary tract infections in postmenopausal women","volume":"22","author":"Jung","year":"2019","journal-title":"Climacteric"},{"issue":"11","key":"10.1016\/j.maturitas.2024.108128_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections","volume":"329","author":"Raz","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.maturitas.2024.108128_bb0055","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/374341","article-title":"Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women","volume":"36","author":"Raz","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.maturitas.2024.108128_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/13697137.2015.1098609","article-title":"Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women","volume":"19","author":"Delgado","year":"2016","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.maturitas.2024.108128_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/GME.0000000000001497","volume":"27","author":"Hirschberg","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108128_bb0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society","volume":"17","author":"The North American Menopause Society","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108128_bb0075","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/gme.0b013e3182518e9a","article-title":"The therapeutic effect of a new ultra low concentration estriol gel formulation (0.0005% estriol, vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study","volume":"19","author":"Cano","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108128_bb0080","first-page":"87","article-title":"The new science of estrogen receptors","author":"Maddox","year":"1999","journal-title":"Pharmacist"},{"key":"10.1016\/j.maturitas.2024.108128_bb0085","unstructured":"Mas M. Tratamiento de la atrofia urogenital mediante administraci\u00f3n intravaginal de estr\u00f3genos a bajas dosis, con especial referencia al estriol. Bases fisiol\u00f3gicas y farmacol\u00f3gicas. [Treatment of urogenital atrophy by intravaginal administration of estrogens at low doses, with special reference to estriol. Physiological and pharmacological basis]. Prog Obstet Ginecol 2011;54(Supl. 2):1\u201321."},{"key":"10.1016\/j.maturitas.2024.108128_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.24140","article-title":"Management of menopausal symptoms: a review","volume":"329","author":"Crandall","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2024.108128_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697137.2020.1820478","article-title":"Vaginal libricants and moisturizers: a review into use, efficacy, and safety","volume":"24","author":"Potter","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2024.108128_bb0100","doi-asserted-by":"crossref","unstructured":"Delgado Mar\u00edn JL, Est\u00e9vez Tesouro J, Su\u00e1rez Almarza J, et al. Sexual health in women with vaginal atrophy. Results of a non-hormonal vaginal gel in women with severe dyspareunia. A Poster Presentaci\u00f3n. 21st ESGO congress of the European Society for Gynaecological Oncology; 2019; Athens, Greece.","DOI":"10.1136\/ijgc-2019-ESGO.1140"},{"key":"10.1016\/j.maturitas.2024.108128_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bju.15756","article-title":"Guideline of guidelines: management of recurrent urinary tract infections in women","volume":"130","author":"Kwok","year":"2022","journal-title":"BJU Int."},{"key":"10.1016\/j.maturitas.2024.108128_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ucl.2021.12.004","article-title":"Medical treatment for urinary tract infections","volume":"49","author":"Ross","year":"2022","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.maturitas.2024.108128_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/354084","article-title":"Incidence and diversity of antimicrobial multidrug resistance profiles of uropathogenic bacteria","volume":"2015","author":"Linhares","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.maturitas.2024.108128_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjmed.2022.03.015","article-title":"Asymptomatic bacteriuria: prevalence, diagnosis, management, and current antimicrobial stewardship implementation","volume":"135","author":"Luu","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.maturitas.2024.108128_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.maturitas.2017.02.004","article-title":"Preventing urinary tract infections after menopause without antibiotics","volume":"99","author":"Caretto","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2024.108128_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/jwh.2017.6385","article-title":"Overall safety of ospemifene in postmenopausal women from placebo-controlled phase 2 and 3 trials","volume":"27","author":"Simon","year":"2018","journal-title":"J. Womens Health"},{"issue":"1","key":"10.1016\/j.maturitas.2024.108128_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/GME.0000000000000485","article-title":"Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel","volume":"23","author":"Caruso","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108128_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2021.04.005","article-title":"Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: an EMAS clinical guide","volume":"148","author":"Hirschberg","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2024.108128_bb0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/09513590.2019.1702016","article-title":"Local ultra-low-dose estriol gel treatment of vulvo-vaginal athophy: efficacy and safety of long-term treatment","volume":"36","author":"Villa","year":"2020","journal-title":"Gynecol. Endocrinol."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224002238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224002238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T20:38:51Z","timestamp":1738096731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512224002238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0378512224002238"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.108128","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of an ultra-low-dose 0.005\u00a0% estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.108128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108128"}}